Biotechnology Stocks I Performance Guide: Zentalis Pharmaceuticals, Inc. (ZNTL)
ZNTL has no dividends.
Table and Chart of ZNTL Performance
See what a $1,000 investment in ZNTL is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ZNTL Returns | |
|---|---|
| Start Date | May-29-2020 |
| Start Price | $52.22 |
| End Date | Jul-26-2024 |
| End Price | $4.47 |
| # Prices | 51 |
| Min Date | Jun-28-2024 |
| Min Price | $4.09 |
| Max Date | Dec-31-2021 |
| Max Price | $84.06 |
| Total Return | -91.44% |
| Annualized Return | -43.92% |
| Current Value of $1,000 Purchase | $86 |
| Number Returns | 1,275 |
| Average Return | -33.08% |
| Number Profitable Returns | 261 |
| Percent Profitable Returns | 20.47% |
| Number Unprofitable Returns | 1,014 |
| Percent Unprofitable Returns | 79.53% |
| Profitable to Unprofitable Returns Ratio | 0.26 |
| ZNTL Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $309,618,000 |
| Beta | 1.705 | Price to Sales |
| Earnings per Share | $-3.2600 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 2.176 |
| PRICE DATA | |
| 52 Week High | $29.03 |
| 52 Week Low | $3.27 |
| Analyst Target Price | $10.7 |
| 50-Day Moving Average | $7.48 |
| 200-Day Moving Average | $12.18 |
| FINANCIAL DATA | |
| Revenue per Share | $0.594 |
| Revenue | $40,560,000 |
| Profit Margin | 0% |
| Return on Equity | -51.9% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ZNTL Compare Returns with S&P 500
ZNTL Trendline Chart
ZNTL Moving Average Chart
ZNTL Stock Return Map - See Patterns of Gains and Losses
ZNTL Stock Returns/Purchase Dates